Mezzion Pharma Co., Ltd.
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
140410 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 삼성로 570 석천빌딩 7층, 서울특별시
- Website:
- https://mezzion.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mezzion Pharma Co., Ltd. is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics, with a particular emphasis on rare diseases. The company's primary efforts are centered on its drug candidate, udenafil, for various medical conditions. A key initiative is the development of udenafil for adolescents living with Fontan circulation, a rare congenital heart condition, supported by a large-scale Phase 3 clinical trial (FUEL-2). Mezzion's pipeline also includes potential treatments for pulmonary arterial hypertension (PAH), portal hypertension, and erectile dysfunction. The company's business model involves developing pharmaceutical products and out-licensing them for international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 14.7 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.9 KB | ||
| 2025-06-20 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 6.0 KB | ||
| 2025-06-20 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 6.0 KB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 101.3 KB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 107.8 KB | ||
| 2025-06-10 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 67.0 KB | ||
| 2025-06-10 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 94.9 KB | ||
| 2025-06-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 972.3 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.7 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.5 MB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.8 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 143.7 KB |
Automate Your Workflow. Get a real-time feed of all Mezzion Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mezzion Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
